Celebrating the International Day of Women and Girls in Science
LifeArc celebrates the UN’s International day of Women and Girls in Science, joining the call to remove any barriers that hold women back
Our Seed Fund is investing £1million in Pheno Therapeutics to identify and develop potential new treatments that pr… https://t.co/TgpoBPhAb9
Alliance enables clinical trial of experimental treatment for epidermolysis bullosa
An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to start trials in patients thanks to the perseverance of the charity team at LifeArc.
Melanie Lee, a life in life sciences
Melanie Lee, LifeArc CEO, reflects on a career in life sciences leading to her win of the BIA Lifetime Achievement Award in 2019.
LifeArc AUTM Fellows programme – a look at 2018’s alumni
Here we look back at the experiences of last years’ alumni and hope to provide insight into the programme for future candidates.
Collaboration: Just the latest buzzword in medical research?
(Blog first appeared on AMRC website on 4 December 2017. ) Mike Johnson, Executive Director, Business Development,…
LifeArc splashes out, fuelled by Keytruda
Article in Nature Biotechnology about our new name and plans for the future (subscription needed to read…
Putting patient wellbeing and collaboration at the heart of what we do
Which treatment or diagnostic would make a patient’s life better? This is the starting point of what…
Rethinking drug research, before it’s too late
As we face the prospect of living in a ‘post-antibiotic’ era, there is renewed urgency to rethink…
Immunotherapy drugs could herald new era in cancer treatment
Immunotherapy, which uses the body’s own defence mechanism, is at long last becoming accepted as a frontline treatment for cancer, taking its place alongside conventional chemotherapy and radiation-based treatments.